Opinion: Clinical research doesn’t reflect the Alzheimer’s population. That needs to change
New data from the National Institute on Aging (NIA), part of the National Institutes of Health, show that our nation needs a fundamental shift in how Alzheimer’s research and clinical trials are designed and funded to overcome urgent health equity challenges.
Alzheimer’s — a progressive brain disease that slowly erodes memory and executive function over time — disproportionately affects people of color, yet health disparities in Alzheimer’s treatment and research remain under-addressed.
